Chris Simpson is a shareholder in Polsinelli’s Venture Capital and Emerging Growth Companies Practice Group. Chris advises companies at all stages of growth, from start-ups to ready-to-IPO/exit, helping them successfully raise capital, complete acquisitions and divestitures, and address day to day operative and commercial matters.

Venture Capital and Growth Equity

A significant portion of Chris’ practice is dedicated to working with entrepreneurs and early growth stage companies, and Chris has helped countless companies navigate their way through Series Seed, A and B fundraises to exit transactions.

Chris also counsels venture capital and growth equity funds in connection with their debt and equity financing investments in private companies.

General Outside Counsel

Chris works as general outside counsel to private companies, helping them with day-to-day legal guidance and larger strategic transactions.

AgTech, Food and Beverage, Tech and Life Sciences

Chris expertly advises agtech, food and beverage, tech and life science companies from start-up stage to public companies on various corporate matters including negotiating investments, mergers and acquisitions, strategic collaborations and joint ventures and public offerings.

Cross-Border Experience

A large portion of Chris’ experience has involved cross-border transactions in the life sciences and agtech space, including cross-border acquisitions, financings, joint ventures and collaborations.

Before Polsinelli, Chris practiced at Choate, Hall & Stewart, LLP in Boston Massachusetts.

  • Represented Cresicor, Inc. a consumer packaged goods trade management platform startup its recent $5.6 million Series Seed Financing.
  • Representation of Sketchfab, Inc. the largest platform for immersive and interactive 3D, in a merger with Epic Games.
  • Representation of The Citizenry, Inc. a direct to consumer home decor brand that partners with artisans around the world, on its $20 million Series B Financing.
  • Representation of a private agtech company in a $25MM equity fundraise.
  • Representation of a private agtech company in $80MM sale to international publicly traded company.
  • Representation of a private seed company in a seven figure equity fundraise.
  • Representation of a food and beverage company in a $10MM equity fundraise. 
  • Representation of numerous other agtech, food and beverage, life science and technology companies in seed, Series A and successive rounds of venture capital and growth equity financings. 
  • Representation of leading venture capital firm in financing of CPG companies.
  • Representation of publicly-traded pharmaceutical company in $1 billion+ acquisition of drug-development company. 
  • Representation of a pre-commercial drug development company in a number of cross-border research and licensing collaborations with non-US companies and universities. 
  • Representation of a Swiss medical device company in its sale to a US publicly-traded company.